{"transactions":[{"id":1425418,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":88070,"kind":"person","name":"Halperin Wernli Miri","position":1,"cik":"0001897615","reported_name":"Halperin Wernli Miri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T20:30:13.000Z","date":"2024-08-21","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the option to purchase 50,000 common shares of the Issuer, which vested over a period of four years following the date of the grant of February 27, 2020. All such options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2025-02-27","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-099872","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017024099872/ownership.xml","form_type":"4"}},{"id":1425417,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":88070,"kind":"person","name":"Halperin Wernli Miri","position":1,"cik":"0001897615","reported_name":"Halperin Wernli Miri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive President"}}],"security":"Common Shares","published_at":"2024-08-22T20:30:13.000Z","date":"2024-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":32595,"price":6.17,"value":201111.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction represents a \"net exercise\" of an outstanding stock option to purchase an aggregate of 50,000 common shares of the Issuer granted on February 27, 2020. The Reporting Person received 17,405 common shares of the Issuer on the net exercise of the stock option. The Issuer withheld 32,595 common shares underlying the stock option for payment of the exercise price and tax withholding using a stock price of $6.17, which represents the closing price of the Issuer's common shares on August 20, 2024, the day before the exercise."}],"balance_after":202405,"source":{"system":"sec-edgar","filing":"0000950170-24-099872","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017024099872/ownership.xml","form_type":"4"}},{"id":1425416,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":88070,"kind":"person","name":"Halperin Wernli Miri","position":1,"cik":"0001897615","reported_name":"Halperin Wernli Miri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive President"}}],"security":"Common Shares","published_at":"2024-08-22T20:30:13.000Z","date":"2024-08-21","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":3.7,"value":185000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise of Reporting Person's stock option that would otherwise expire February 27, 2025."}],"balance_after":235000,"source":{"system":"sec-edgar","filing":"0000950170-24-099872","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017024099872/ownership.xml","form_type":"4"}},{"id":1610175,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":88070,"kind":"person","name":"Halperin Wernli Miri","position":1,"cik":"0001897615","reported_name":"Wernli Miri Halperin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-29T21:45:50.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest and become exercisable in 48 equal monthly installments, with  the first installment vesting on March 27, 2024, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":4.98,"expiration_date":"2034-02-26","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-023205","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017024023205/ownership.xml","form_type":"4"}},{"id":1914951,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":88070,"kind":"person","name":"Halperin Wernli Miri","position":1,"cik":"0001897615","reported_name":"Wernli Miri Halperin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive President"}}],"security":"Common Shares","published_at":"2023-04-24T23:33:02.000Z","date":"2023-03-14","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 14, 2023, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":185000,"source":{"system":"sec-edgar","filing":"0001209191-23-025475","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919123025475/doc4a.xml","form_type":"4/A","original_submission_date":"2023-03-17"}},{"id":1947286,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":88070,"kind":"person","name":"Halperin Wernli Miri","position":1,"cik":"0001897615","reported_name":"Wernli Miri Halperin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive President"}}],"security":"Common Shares","published_at":"2023-03-17T22:39:24.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 14, 2023, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":1375000,"source":{"system":"sec-edgar","filing":"0001209191-23-019893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919123019893/doc4.xml","form_type":"4"}},{"id":2316728,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":88070,"kind":"person","name":"Halperin Wernli Miri","position":1,"cik":"0001897615","reported_name":"Wernli Miri Halperin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive President"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-29T00:24:11.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":780000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The option grant has an exercise price of $1.48 Canadian Dollars. This represents the exercise price in United States Dollars."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest and become exercisable with 1/48th of the total shares vesting monthly over 48 months from the vesting commencement date, March 24, 2022, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date."}],"balance_after":4462500,"derivative":{"exercise_price":1.18,"expiration_date":"2022-03-23","underlying":"Subordinate Voting Shares","underlying_shares":780000},"source":{"system":"sec-edgar","filing":"0001209191-22-021391","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122021391/doc4.xml","form_type":"4"}},{"id":2316727,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":88070,"kind":"person","name":"Halperin Wernli Miri","position":1,"cik":"0001897615","reported_name":"Wernli Miri Halperin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive President"}}],"security":"Subordinate Voting Shares","published_at":"2022-03-29T00:24:11.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest in 48 equal monthly installments beginning on April 24, 2022, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":1275000,"source":{"system":"sec-edgar","filing":"0001209191-22-021391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122021391/doc4.xml","form_type":"4"}}]}